CorpusAnalytiX, a transformative healthcare data brokerage platform, and Ariana Pharma, a leading AI drug development company, today announced a strategic partnership to accelerate drug development and provide researchers access to previously siloed datasets critical for advancing innovation in pathology, oncology, genomics, and more, fueling deep scientific knowledge extraction using eXplainable AI.